Your browser doesn't support javascript.
loading
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer.
Nolan-Stevaux, Olivier; Li, Cong; Liang, Lingming; Zhan, Jinghui; Estrada, Juan; Osgood, Tao; Li, Fei; Zhang, Hanzhi; Case, Ryan; Murawsky, Christopher M; Estes, Bram; Moore, Gregory L; Bernett, Matthew J; Muchhal, Umesh; Desjarlais, John R; Staley, Binnaz K; Stevens, Jennitte; Cooke, Keegan S; Aeffner, Famke; Thomas, Oliver; Stieglmaier, Julia; Lee, Jae-Lyun; Coxon, Angela; Bailis, Julie M.
Afiliação
  • Nolan-Stevaux O; Oncology Research, Amgen Research, Amgen Inc., South San Francisco, California.
  • Li C; Oncology Research, Amgen Research, Amgen Inc., South San Francisco, California.
  • Liang L; Oncology Research, Amgen Research, Amgen Inc., South San Francisco, California.
  • Zhan J; Oncology Research, Amgen Research, Amgen Inc., Thousand Oaks, California.
  • Estrada J; Oncology Research, Amgen Research, Amgen Inc., Thousand Oaks, California.
  • Osgood T; Oncology Research, Amgen Research, Amgen Inc., Thousand Oaks, California.
  • Li F; Structural Biology, Amgen Research, Amgen Inc., South San Francisco, California.
  • Zhang H; Structural Biology, Amgen Research, Amgen Inc., South San Francisco, California.
  • Case R; Lead Discovery and Characterization, Amgen Research, Amgen Inc., South San Francisco, California.
  • Murawsky CM; Therapeutic Discovery, Amgen Research, Amgen Inc., Burnaby, Canada.
  • Estes B; Therapeutic Discovery, Amgen Research, Thousand Oaks, California.
  • Moore GL; Xencor, Inc., Pasadena, California.
  • Bernett MJ; Xencor, Inc., Pasadena, California.
  • Muchhal U; Xencor, Inc., Pasadena, California.
  • Desjarlais JR; Xencor, Inc., Pasadena, California.
  • Staley BK; Oncology Research, Amgen Research, Amgen Inc., South San Francisco, California.
  • Stevens J; Therapeutic Discovery, Amgen Research, Thousand Oaks, California.
  • Cooke KS; Oncology Research, Amgen Research, Amgen Inc., Thousand Oaks, California.
  • Aeffner F; Translational Safety and Bioanalytical Sciences, Amgen Research, Amgen Inc., South San Francisco, California.
  • Thomas O; Translational Safety and Bioanalytical Sciences, Amgen Research (Munich) GmbH, Munich, Germany.
  • Stieglmaier J; Early Development Oncology, Amgen Research (Munich) GmbH, Munich, Germany.
  • Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Coxon A; Oncology Research, Amgen Research, Amgen Inc., Thousand Oaks, California.
  • Bailis JM; Oncology Research, Amgen Research, Amgen Inc., South San Francisco, California.
Cancer Discov ; 14(1): 90-103, 2024 01 12.
Article em En | MEDLINE | ID: mdl-37861452
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article